Scientists at University College London carried out the trial in 16 countries across Asia, Europe, North America, and South America
Book here
The good news is that the routine itself is simple
Semaglutide is the active ingredient in several FDA-approved weight loss medications, including Ozempic and Wegovy
As research continues, there is hope that semaglutide could become an important part of managing colitis and improving the quality of life for those affected
It was approved in the UK in 2023 for weight management in adults with: BMI 30 kg/m (obesity), or BMI 27 kg/m (overweight) with at least one weight-related condition The medication works in several ways: Reduces hunger signals by acting on the brains appetite control centre Slows stomach emptying , creating longer-lasting fullness after meals Reduces food cravings , particularly for ultra-processed foods Clinical trials show that people taking Wegovy lose an average of 15% of their body weight after 68 weeks, compared to 2.4% with placebo
.webp)
